Huntsman Cancer Institute ( Site 5041) — Salt Lake City, Utah

Public research footprint of Huntsman Cancer Institute ( Site 5041), compiled from the ClinicalTrials.gov public registry.

1,445

Registered studies

546

Active

256

Recruiting now

636

Completed

219

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia · Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm · Anatomic Stage II Breast Cancer AJCC v8 · Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Recently updated registry entries

NCT05091424 — A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a… (Recruiting)
NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)
NCT04858334 — APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Huntsman Cancer Institute ( Site 5041)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.